V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011742 | 310005410 | 1.7 | null | Not known (9) | 2017-08-21 | 2018-07-22 | Capecitabine + Oxaliplatin 21day | 2 | N | 310000469 | LENALIDOMIDE |
| 310011743 | 310005429 | 1.67 | 64.4 | Palliative (P) | 2017-11-01 | 2017-11-17 | ICE (no GCSF) | N | Y | 310001330 | METHOTREXATE HIGH DOSE |
| 310011744 | 310008409 | 1.57 | null | Disease modification (D) | 2019-04-13 | 2019-04-14 | Trastuzumab Subcutaneous | null | null | 310003601 | MTX HD + PROCARBAZINE + VINCRISTINE |
| 310011745 | 310005468 | null | 101.7 | Disease modification (D) | 2018-11-28 | 2018-12-02 | VINCRISTINE | null | null | 310003672 | METHOTREXATE HIGH DOSE |
| 310011746 | 310005472 | 1.53 | 71.5 | Adjuvant (A) | 2016-08-06 | 2017-10-10 | Retinoblastoma JOE | 02 | Y | 310003732 | MCX |
| 310011747 | 310005475 | 1.85 | null | Palliative (P) | 2019-04-04 | 2019-04-16 | Oxaliplatin + Modified de Gramont | null | null | 310003761 | DTPACE |
| 310011748 | 310005489 | 1.48 | 62.45 | null | 2016-05-04 | 2016-05-19 | UKALL14- Cons Cycle 1 | 2 | N | 310005975 | ICON TRIAL |
| 310011749 | 310005494 | 1.63 | 56.4 | Palliative (P) | 2016-10-23 | 2016-10-24 | BEAM + FLUDARABINE | 02 | N | 310006698 | OCTOPUS TRIAL |
| 310011750 | 310005499 | 1.5 | 47.2 | Palliative (P) | 2017-01-24 | 2017-01-24 | ICON8B TRIAL | 2 | N | 310007286 | PEMETREXED |
| 310011751 | 310008433 | 1.73 | 62.6 | null | 2014-10-28 | 2014-10-29 | LENALIDOMIDE | 02 | N | 310007558 | FEC |
| 310011752 | 310005521 | 1.68 | 58 | Palliative (P) | 2016-08-31 | 2016-08-31 | Vemurafenib | Y | null | 310011231 | CAPECITABINE |
| 310011753 | 310010006 | 1.57 | null | Palliative (P) | 2018-01-06 | 2018-01-06 | Cytarabine High Dose | N | null | 310012353 | TRABECTEDIN |
| 310011754 | 310005577 | 1.64 | null | Palliative (P) | 2018-12-22 | 2019-01-01 | Trabectedin | 02 | N | 310021471 | MELPHALAN |
| 310011755 | 310008476 | 1.65 | null | Curative (C) | 2016-02-18 | 2016-02-18 | Topotecan (intravenous) | N | N | 310021589 | CETUXIMAB + RT |
| 310011756 | 310008482 | 1.82 | 64 | Palliative (P) | 2016-06-04 | 2016-06-12 | Methotrexate High Dose (3g/m2) | N | N | 310022562 | IFOSFAMIDE |
| 310011757 | 310005598 | 0 | null | Palliative (P) | 2015-11-18 | 2015-11-18 | Vemurafenib | N | null | 310022751 | CISPLATIN + FLUOROURACIL |
| 310011758 | 310010034 | 1.83 | null | Palliative (P) | 2016-10-20 | 2016-11-06 | CAPECITABINE + OXALIPLATIN | N | N | 310023408 | OXALIPLATIN + MDG |
| 310011759 | 310005639 | 1.57 | null | Palliative (P) | 2018-04-06 | 2018-08-19 | Capecitabine | null | null | 310024263 | TOPOTECAN |
| 310011760 | 310008514 | 1.62 | 8.9 | Curative (C) | 2018-11-26 | 2018-11-30 | Oxaliplatin + Modified de Gramont | N | N | 310024565 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310011761 | 310005670 | 1.8 | 66.45 | Palliative (P) | 2019-01-27 | 2019-02-05 | Cetuximab + Radiotherapy Maint | null | null | 310025467 | METHOTREXATE |
| 310011762 | 310005674 | 0.6 | 83.9 | Palliative (P) | 2019-10-01 | 2019-10-29 | Temozolomide 200mg/m2 | 02 | N | 310025486 | MPV |
| 310011763 | 310008536 | 1.65 | null | Palliative (P) | 2017-05-28 | 2017-06-06 | Doxorubicin 75mg/m2 | N | N | 310003715 | TRASTUZUMAB |
| 310011764 | 310005731 | 1.78 | 68.8 | Palliative (P) | 2019-07-30 | 2019-07-30 | Sunitinib | null | null | 310024445 | METHOTREXATE HIGH DOSE |
| 310011765 | 310009320 | 1.65 | 57 | Palliative (P) | 2020-03-14 | 2020-03-22 | Carboplatin AUC 6 - 10 | 02 | N | 310004157 | CARBOPLATIN |
| 310011766 | 310002777 | 1.56 | 70 | Palliative (P) | 2013-08-31 | 2015-11-19 | Paclitaxel 7 day | N | N | 310004177 | PACLITAXEL |
| 310011767 | 310007151 | 1.62 | 71.6 | Palliative (P) | 2016-08-18 | 2016-08-18 | Carboplatin AUC 2 - 5 | N | N | 310004295 | CARBOPLATIN |
| 310011768 | 310002833 | 1.58 | 50 | Palliative (P) | 2017-09-07 | 2017-09-17 | PACLITAXEL | N | N | 310004358 | PACLITAXEL |
| 310011769 | 310002847 | 1.66 | null | Palliative (P) | 2016-05-26 | 2016-05-26 | Carboplatin AUC 6 - 10 | 02 | N | 310004381 | CARBOPLATIN |
| 310011770 | 310002910 | 1.52 | 77 | Palliative (P) | 2014-11-29 | 2014-12-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 310004634 | CARBOPLATIN + PACLITAXEL |
| 310011771 | 310007191 | null | null | Palliative (P) | 2016-06-16 | 2016-07-02 | Carboplatin AUC 6 - 10 | 02 | null | 310004655 | CARBOPLATIN |
| 310011772 | 310002949 | 1.59 | 74.4 | Palliative (P) | 2019-08-08 | 2019-08-11 | Carboplatin AUC 2 - 5 | 02 | N | 310004719 | CARBOPLATIN |
| 310011773 | 310002962 | null | 81.6 | Palliative (P) | 2015-12-28 | 2016-01-04 | Paclitaxel 7 day | N | null | 310004777 | PACLITAXEL |
| 310011774 | 310002976 | null | 65 | Palliative (P) | 2018-07-06 | 2018-07-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 310004829 | CARBOPLATIN + PACLITAXEL |
| 310011775 | 310002982 | 1.57 | 65 | Not known (9) | 2016-02-21 | 2016-02-22 | PACLITAXEL | N | Y | 310004831 | PACLITAXEL |
| 310011776 | 310002990 | 1.54 | 73 | Palliative (P) | 2019-05-28 | 2019-06-02 | PACLITAXEL | N | N | 310004848 | PACLITAXEL |
| 310011778 | 310003238 | null | null | Palliative (P) | 2013-11-07 | 2014-07-05 | Carboplatin + Paclitaxel (weekly) | 02 | N | 310005683 | CARBOPLATIN + PACLITAXEL |
| 310011779 | 310003263 | 1.67 | 103.8 | Curative (C) | 2016-08-24 | 2016-09-14 | Carboplatin AUC 2 - 5 | 02 | N | 310005719 | CARBOPLATIN |
| 310011780 | 310003294 | 1.68 | null | Palliative (P) | 2019-09-22 | 2019-10-11 | Bevacizumab | 02 | N | 310005782 | BEVACIZUMAB |
| 310011781 | 310009415 | 1.72 | 63 | Disease modification (D) | 2019-07-22 | 2019-08-04 | Trial Unspecified | Y | N | 310005803 | TRIAL |
| 310011782 | 310003341 | null | 76 | Palliative (P) | null | 2016-05-19 | Bevacizumab 7.5mg/kg | N | N | 310005921 | BEVACIZUMAB |
| 310011783 | 310003349 | 1.79 | null | Palliative (P) | 2020-01-25 | 2020-02-01 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310005941 | LIPOSOMAL DOXORUBICIN |
| 310011784 | 310007385 | null | 59.4 | Palliative (P) | 2017-07-16 | 2017-07-22 | CARBOPLATIN + GEMCITABINE | 2 | N | 310006270 | GEMCARBO |
| 310011785 | 310003484 | 1.59 | 61.7 | Palliative (P) | 2018-10-29 | 2018-10-29 | CHOP - 21 days | null | Y | 310006394 | CHOP |
| 310011786 | 310007405 | null | 66.4 | Palliative (P) | 2019-01-21 | 2019-07-24 | GemCarbo Days 1+8 | 2 | N | 310006435 | GEMCARBO |
| 310011787 | 310003520 | 1.73 | 87.2 | Palliative (P) | 2015-05-03 | 2015-05-06 | GemCarbo Days 1+8 | N | N | 310006576 | GEMCARBO |
| 310011788 | 310003531 | 1.77 | 112 | Palliative (P) | 2018-06-05 | 2018-06-06 | Trial Unspecified | N | N | 310006623 | TRIAL |
| 310011789 | 310003664 | null | 101 | Curative (C) | 2015-02-08 | 2015-04-08 | CHOP - 14 days | N | N | 310007089 | CHOP |
| 310011790 | 310003680 | null | 83 | Palliative (P) | 2017-06-17 | 2017-07-15 | CEOP | N | N | 310007131 | CHOP |
| 310011791 | 310011883 | 1.49 | 60.4 | Disease modification (D) | 2018-04-21 | 2018-05-19 | Trial Unspecified | Y | N | 310007215 | TRIAL |
| 310011792 | 310003790 | 1.63 | 59.9 | Neo-adjuvant (N) | 2015-05-01 | 2015-05-01 | GEMCARBO | 02 | N | 310007569 | GEMCARBO |